Records containing: Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-11-18Feasibility of Measuring Cerebrospinal Fluid (CSF) Signatures in Subjects With Intrathecal Catheter-Related Problems
-
CLINICAL_TRIALS study record update · 2013-10-30A Randomized, Controlled, Open-Label Parallel Group Study to Evaluate the Effect of Regularly Scheduled Neutralizing Antibody Testing on Treatment Patterns Versus Usual Care in High-Dose Interferon Treated Patients
-
CLINICAL_TRIALS study record update · 2013-10-28Double-blind Extension of the Study 27025 (REFLEX) to Obtain Long-term Follow-up Data in Patients With Clinically Definite MS and Patients With a First Demyelinating Event at High Risk of Converting to MS, Treated With Rebif® New Formulation (REFLEXION)
-
CLINICAL_TRIALS study record update · 2013-10-22Effect of Sodium Intake in Multiple Sclerosis Disease Activity
-
CLINICAL_TRIALS study record update · 2013-10-17An Open-Label, Multicenter Study Evaluating Patient Injection Satisfaction With Two Formulations of Glatiramer Acetate (GA) Using Autoject 2 as the Subcutaneous Injection Delivery Method.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-10-16The Multiple Sclerosis Functional Composite (MSFC) in the Follow-up of MS Patients: Correlation With the Expanded Disability Status Scale (EDSS) Among Different Clinical Forms in Argentina
-
CLINICAL_TRIALS study record update · 2013-10-14The Impact of Armodafinil on Neurocognition and Cognitive Fatigue in Multiple Sclerosis: a Double-Blind Randomized Crossover Study
-
CLINICAL_TRIALS study record update · 2013-10-14An Open-label, Proof of Concept Study to Evaluate Multiple Gait and Balance Parameters After Withdrawal of Dalfampridine-ER 10mg in Subjects With MS
-
CLINICAL_TRIALS study record update · 2013-10-10A Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Trial of Oral Cladribine in Subjects With a First Clinical Event at High Risk of Converting to MS
-
CLINICAL_TRIALS study record update · 2013-10-08Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2013-09-26Modafinil for Improving New Learning and Memory in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2013-09-23Gait Rehabilitation for Multiple Sclerosis Using Robot-assisted Body-weight-supported Treadmill Training (Lokomat)
-
CLINICAL_TRIALS study record update · 2013-09-23Robot-assisted Ankle Rehabilitation for Multiple Sclerosis (Anklebot)
-
CLINICAL_TRIALS study record update · 2013-09-20Pilot Study on Gait & Motor Function in MS Using BWS Treadmill Training
-
CLINICAL_TRIALS study record update · 2013-09-16An Open-Label, Survey-Based, Multicenter Study to Determine Patient Satisfaction With Single-Use Prefilled Avonex® PEN Autoinjector in Multiple Sclerosis Patients
-
CLINICAL_TRIALS study record update · 2013-09-16Measuring Neutralizing Antibodies in the Patients Treated With Interferon Beta 1a IM, in Mexico and Colombia
-
CLINICAL_TRIALS study record update · 2013-09-16An Open-Label Study to Evaluate the Safety and Tolerability and to Explore the Efficacy of Avonex (Interferon Beta-1a) in Chinese Subjects With Relapsing Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2013-09-10Phase II Study of the Effects of Stress Management on Neuroimaging, Clinical, Immune and Psychosocial Outcomes
-
CLINICAL_TRIALS study record update · 2013-09-04An Extension of the 6-month, Double-blind, Randomized, Placebo-controlled, Parallel-group, Multicenter Study Comparing Efficacy and Safety of FTY720 0.5 mg and 1.25 mg Administered Orally Once Daily in Patients With Relapsing Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2013-08-30A Multicenter, Open-label Randomized Crossover Trial to Assess Subject Preference for Kemstro™ Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2013-08-30Efficacy of Telephone-Delivered Cognitive Behavioral Therapy for Chronic Pain
-
CLINICAL_TRIALS study record update · 2013-08-22Validation of a Hand-Held Dynamometer for Assessment of Lower Limb Muscle Strength in Multiple Sclerosis: Protocol for Strength Testing and Reliability Characteristics
-
CLINICAL_TRIALS study record update · 2013-08-13Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Two Doses of Oral Dalfampridine Extended Release Tablets (5 mg and 10 mg Twice Daily) in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2013-08-08Effect of a Training Regime Featuring the I-TRAVLE System on Arm Function and Skill Performance in Persons With Multiple Sclerosis and Chronic Stroke Patients: a Single Arm Trial
-
CLINICAL_TRIALS study record update · 2013-08-01Comprehensive Analysis of Relapse in Multiple Sclerosis